#	Pagina
attuale pagina	/open-h2020/projects/213019/index.html

Opendata, web and dolomites

COLOSTEO SIGNED

Nutraceutical supplementation based on colostrum for prevention of osteoporosis

Total Cost €

EC-Contrib. €

Partnership

Views

COLOSTEO project word cloud

Explore the words cloud of the COLOSTEO project. It provides you a very rough idea of what is the project "COLOSTEO" about.

advantage economic colosteo prevention hinders constitutes constituents pharmacological 25 possibility health reported ideas academic nutraceutical indicate natural reduce agent 2010 industry drugs exchange expertise absence intersectorial fractures estimates osteoporotic bone public community accordance scientific osteoporosis skills decreasing create probably metabolism received actually prevent colostrum market transferred gap innovative 2025 secondments confers bridging fill inefficiency burden consequence industrial creation lack agents

Project "COLOSTEO" data sheet

The following table provides information about the project.

Coordinator	PANEPISTIMIO THESSALIAS Organization address address: ARGONAFTON FILELLINON city: VOLOS postcode: 38221 website: www.uth.gr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Greece [EL]
Total cost	828˙000 €
EC max contribution	828˙000 € (100%)
Programme	1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
Code Call	H2020-MSCA-RISE-2017
Funding Scheme	MSCA-RISE
Starting year	2018
Duration (year-month-day)	from 2018-01-01 to 2021-12-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	PANEPISTIMIO THESSALIAS PANEPISTIMIO THESSALIAS Organization address address: ARGONAFTON FILELLINON city: VOLOS postcode: 38221 website: www.uth.gr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	EL (VOLOS)	coordinator	207˙000.00
2	CENTRO DE ESTUDIOS SUPERIORES DE LA INDUSTRIA FARMACEUTICA SA CENTRO DE ESTUDIOS SUPERIORES DE LA INDUSTRIA FARMACEUTICA SA Organization address address: CALLE DEL GENERAL ALVAREZ DE CASTRO 41 city: MADRID postcode: 28020 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (MADRID)	participant	207˙000.00
3	CHRISTOS PAPADOPOULOS & SIA OE CHRISTOS PAPADOPOULOS & SIA OE Organization address address: KITROUS EPISKOPOU 71 city: KARDITSA postcode: 431 00 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	EL (KARDITSA)	participant	207˙000.00
4	UNIVERSIDADE DO PORTO UNIVERSIDADE DO PORTO Organization address address: PRACA GOMES TEIXEIRA city: PORTO postcode: 4099 002 website: http://www.up.pt contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	PT (PORTO)	participant	207˙000.00

Map

Project objective

Osteoporosis constitutes a major public health concern. The economic burden of osteoporotic fractures in EU is expected to increase 25% by 2025 compared to 2010. These estimates may indicate an inefficiency of current drugs for osteoporosis. Actually, the use of pharmacological agents for osteoporosis has been decreasing in EU, probably due to the reported side effects. Therefore, there is a need for innovative agents to reduce the burden of osteoporosis. Colostrum is a promising agent against bone loss since it has natural constituents that are directly involved in bone metabolism. As a nutraceutical, colostrum confers an advantage over pharmacological drugs since it can avoid side effects. However, the possibility of its use as a nutraceutical agent for osteoporosis have only received attention within the scientific community. The knowledge produced on the effects of colostrum on bone metabolism has not yet been transferred to the market because academic institutions lack on expertise to create a new product. On the other hand, industry has knowledge on product development, but lack expertise on research skills. In accordance, what hinders the creation of an innovative product based on colostrum for prevention of osteoporosis is the absence of an intersectorial collaboration. As consequence, there is a clearly gap between research on the matter and its application. COLOSTEO aims to fill in this gap by creating an intersectorial collaboration to exchange knowledge and expertise towards the creation of an innovative nutraceutical product based on colostrum to prevent osteoporosis. This aim will be achieved by bridging two academic with two industrial institutions that through intersectorial secondments will exchange knowledge, ideas and expertise towards the creation of an innovative nutraceutical product based on colostrum to prevent osteoporosis.

Deliverables

List of deliverables.
Transfer of Knowledge Activities D3.3-4	Other	2020-01-30 19:57:47

Take a look to the deliverables list in detail: detailed list of COLOSTEO deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "COLOSTEO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "COLOSTEO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.3.)

VIRTUOUS (2019)

Virtual tongue to predIct the oRganoleptic profile of mediterranean IngredienTs and their effect on hUman hOmeostasis by means of an integrated compUtational multiphysicS platform